-
FDA expands B-VEC label to include patients from birth with dystrophic epidermolysis bullosa
15 Sep 2025 22:08 GMT
… patients from birth with dystrophic epidermolysis bullosa, broadening access beyond the prior … patients from birth with dystrophic epidermolysis bullosa (DEB), expanding on the … Study of Patients with Dystrophic Epidermolysis Bullosa. Am J Clin Dermatol. …
-
Krystal Biotech's B-VEC for Dystrophic Epidermolysis Bullosa Gets Expanded FDA Label
15 Sep 2025 17:53 GMT
… patient population to include dystrophic epidermolysis bullosa (DEB) patients from birth. Patients … Study of Patients with Dystrophic Epidermolysis Bullosa. Am J Clin Dermatol. 2025 …
-
DEBRA and Queen Mary partner to advance epidermolysis bullosa drug development
21 Aug 2025 11:43 GMT
… at advancing drug development for epidermolysis bullosa (EB).
The research collaboration will …
-
BioMendics Launches TAMES-02 Clinical Trial for Innovative Epidermolysis Bullosa Simplex Therapy
07 Aug 2025 14:18 GMT
… with generalized intermediate to severe Epidermolysis Bullosa Simplex (EB Simplex).
EB Simplex …
-
Chiesi Global Rare Diseases Spotlights the Profound Impact of Epidermolysis Bullosa in the Film “Living Between Pain and Hope” as part of “The Next Frontier,” a New Series Presented by the Biotechnology Innovation Organization
28 Jul 2025 12:00 GMT
… and Michael, both living with epidermolysis bullosa (EB), a rare and devastating … . Explore the series here. About Epidermolysis Bullosa Epidermolysis Bullosa (EB) is a rare and …
-
Krystal Biotech Announces Approval of VYJUVEK® by Japan’s Ministry of Health, Labour and Welfare for the Treatment of Dystrophic Epidermolysis Bullosa
25 Jul 2025 13:00 GMT
… wounds in patients with dystrophic epidermolysis bullosa (DEB), starting from birth. … April 2025. JAPAN INDICATION
Dystrophic epidermolysis bullosa About Krystal Biotech, Inc.
… for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly …
-
Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa
26 Jun 2025 07:03 GMT
… ) — For patients with recessive dystrophic epidermolysis bullosa (RDEB), a one-time surgical …
-
Cell-based, gene therapy skin grafts heal large epidermolysis bullosa wounds
24 Jun 2025 22:38 GMT
… chronic wounds for patients with epidermolysis bullosa.
The technology could be the … in patients with recessive dystrophic epidermolysis bullosa, according to study results published … in The Lancet.
“Epidermolysis bullosa (EB) is a family of …
-
Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
24 Jun 2025 11:30 GMT
… pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). This article, … Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa Wounds (VIITAL): A … patients with recessive dystrophic epidermolysis bullosa (RDEB). Important Safety …
-
Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
24 Jun 2025 11:00 GMT
… of corneal abrasions in dystrophic epidermolysis bullosa (DEB) patients. KB803 is designed … of eye pain and monthly Epidermolysis Bullosa Eye Disease Index (EB-EDI … for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing …
About
© 1995-2025